Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Natalia Camejo is active.

Publication


Featured researches published by Natalia Camejo.


Journal of Clinical Oncology | 2015

Trastuzumab-induced cardiotoxicity in Uruguayan HER2-positive breast cancer patients.

Andrea Schiavone; Mariana Díaz; Natalia Camejo; Natalia Reborido; Horacio Vázquez; Gabriel Parma; Álvaro Vázquez; Cecilia Castillo; Gabriel Krygier; Lucía Delgado

143 Background: To evaluate the incidence, severity and outcome of Trastuzumab-induced cardiotoxicity in HER2 positive Uruguayan breast cancer (BC) patients. METHODS Retrospective observational analysis of HER2 positive BC patients who were treated with Trastuzumab (TTZ) from January 2007 to December 2013 at two Uruguayan centers. Cardiac monitoring included physical examination and assessment of left ventricular ejection fraction (LVEF) by echocardiography that was evaluated before TTZ administration and every 12 weeks thereafter during the duration of therapy. Cardiovascular risk factors analyzed were: obesity (BMI ≥ 30 kg/m2), hypertension, diabetes, sedentary lifestyle and high cholesterol. RESULTS Sixty nine female patients were found in the databases of our institutions. Median age was 48 years (range: 27-73). Stage at diagnosis was as detailed: 19 % EI, 46 % EII, 29 % EIII and 4 % EIV. Eighty nine percent of patients received adjuvant TTZ , 4 % neoadjuvant TTZ and 7 % received it as a palliative therapy. Thirty patients (43, 5%) had at least one cardiovascular risk factors: 26% hypertension, 16% obesity, 9% sedentary lifestyle, and 4% high cholesterol. Median number of TTZ cycles was 15. Cycles were administered every 3 weeks at standard dose. Nineteen patients (27%) developed cardiotoxicity, of whom 12 had a transient suspension because of a reversible fall in LVEF, 2 had a irreversible reduction in LVEF, and 5 had a symptomatic heart failure. Eighty-nine percent of our patients (62 patients) completed treatment and the rest had a definitive suspension due to a irreversible reduction in LVEF or symptomatic heart failure. Most patients that developed cardiotoxicity (15 out of 19) had cardiovascular risk factors and also most of them (16 out of 19) had received anthracyclines before TTZ. CONCLUSIONS Cardiotoxicity incidence was similar to the incidence reported in the literature and when it was present, in most cases was transient, asymptomatic, and reversible.


Revista Médica del Uruguay | 2010

Expresión tumoral de HER-2, receptores de estrógenos y de progesterona y su relación con características clínico-patológicas en pacientes uruguayas con cáncer de mama

Lucía Delgado; Rodrigo Fresco; Guianeya Santander; Sergio Aguiar; Natalia Camejo; Liliana Ferrero; Valeria González; Silvina Heinzen; Andrea Martínez; Samantha Mauriz; Carlos Meyer; Gustavo Sena; Gonzalo Spera; Luis Ubillos; Franco Xavier; Hugo Deneo; Marta Aghazarian; Robinson Rodríguez; Graciela Sabini


Journal of Clinical Oncology | 2016

HER-2, Hormone Receptors, and clinicopathologic characteristics in Uruguayan breast cancer patients

Lucía Delgado; R. Fresco; G. Santander; S. Aguiar; Natalia Camejo; L. Ferrero; V. Gonzalez; S. Heinzen; A. Martinez; G. Sabini


Revista Médica del Uruguay | 2012

Análisis de sobrevida según perfil biológico de pacientes uruguayas con cáncer de mama

Cecilia Castillo; Natalia Camejo; Lucía Delgado; Rodrigo Fresco; Guianeya Santander; Sergio Aguiar; Valeria González; Silvina Heinzen; Andrea Martínez; Carlos Meyer; Gustavo Sena; Gonzalo Spera; Luis Ubillos; Franco Xavier; Hugo Deneo; Marta Aghazarian; Robinson Rodríguez; Graciela Sabini


Journal of Clinical Oncology | 2011

Survival analysis of breast cancer subtypes assessed by hormone receptors and HER2 tumor expression in Uruguayan women with operable breast cancer.

Natalia Camejo; V. Gonzalez; Cecilia Castillo; Lucía Delgado; L. Ferrero; R. Fresco; G. Santander; S. Aguiar; S. Heinzen; A. Martinez; C. Meyer; G. Sena; G. Spera; L. Ubillos; F. Xavier; R. Rodríguez; G. Sabini


Revista Uruguaya de Medicina Interna | 2018

Evaluación de la calidad de la asistencia y el nivel de satisfacción de las pacientes asistidas en una Unidad Docente Asistencial de Mastología del Hospital de Clínicas "Dr. Manuel Quintela"

Cecilia Cecilia; Natalia Camejo; Nora Artagaveytia; Ana Hernandez; Lucía Delgado


Journal of Clinical Oncology | 2018

Efficacy of trastuzumab for HER-2 positive breast cancer in a real-life setting: A decade of experience under national treatment coverage regulations.

Natalia Camejo; Cecilia Castillo; Rafael Alonso; Emiliano Rivero; Camila Mezquita; Agustin Rosich; Fiamma Dellacasa; Luciana Silveira; Jonathan Nuñez; Lucía Delgado


Anales de la Facultad de Medicina | 2018

Características del cáncer de mama masculino en una población uruguaya

Natalia Camejo; Cecilia Castillo; Andrea Shiavone; Ana Laura Alfonso; Dahiana Amarillo; Franco Xavier; Gabriel Krygier; Lucía Delgado


Revista Médica del Uruguay | 2017

Características clínico-patológicas y evolución del cáncer de mama en mujeres uruguayas jóvenes

Silvina Malvasio; Andrea Schiavone; Natalia Camejo; Cecilia Castillo; Nora Artagaveytia; Carina Di Matteo; Benedicta Caserta; Roberto Notejane; Isabel Alonso; Lucía Delgado


Journal of Clinical Oncology | 2017

Quality indicators at a breast cancer (BC) unit in a Uruguayan university hospital according to the requirements of European Society of Breast Cancer specialists.

Natalia Camejo; Cecilia Castillo; Lucía Richter; Nora Artagaveytia; Ana Hernandez; Lucía Delgado

Collaboration


Dive into the Natalia Camejo's collaboration.

Top Co-Authors

Avatar

Lucía Delgado

University of the Republic

View shared research outputs
Top Co-Authors

Avatar

Cecilia Castillo

University of the Republic

View shared research outputs
Top Co-Authors

Avatar

Franco Xavier

University of the Republic

View shared research outputs
Top Co-Authors

Avatar

Gabriel Krygier

University of the Republic

View shared research outputs
Top Co-Authors

Avatar

Andrea Martínez

University of the Republic

View shared research outputs
Top Co-Authors

Avatar

Gonzalo Spera

University of the Republic

View shared research outputs
Top Co-Authors

Avatar

Graciela Sabini

University of the Republic

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Gustavo Sena

University of the Republic

View shared research outputs
Top Co-Authors

Avatar

Hugo Deneo

University of the Republic

View shared research outputs
Researchain Logo
Decentralizing Knowledge